For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation (AFib), one of the nation's most common heart ailments. The ...

For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation (AFib), one of the nation's most common heart ailments. The ...

For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation (AFib), one of the nation's most common heart ailments. The ...

(The Mount Sinai Hospital / Mount Sinai School of Medicine) For the first time in a new US clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation ...

A White Paper released today by the Centre for Innovation in Complex Care (CICC), of the University Health Network (UHN), has identified significant care gaps of atrial fibrillation (AF) patients in Ontario, which contribute to debilitating strokes that could be prevented. As a result, the burden of AF-related stroke on ...

Denver, CO (May 18, 2010) -- Dr. Marcos Daccarett, an assistant professor at the University of Utah School of Medicine, won the Young Investigator Award at the Heart Rhythm Society's (HRS) annual scientific sessions in Denver, May 12-15. He was recognized for his presentation of an abstract entitled, "Left ...

ST. LOUIS , May 13 /- Stereotaxis' (Nasdaq: STXS ) safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions ...

March 22, 2010 Washington, D.C. AF Stat a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by atrial fibrillation (AFib) today unveiled the "AFib Educator," a smartphone app and desktop widget to help healthcare practitioners better explain ...

As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial ...

Atrial fibrillation (Afib) is the most common type of abnormal heart beat. It is characterized by scarring of the atrial region of the heart (a hallmark known as atrial fibrosis). Although atrial fibrosis is thought to perpetuate Afib, exactly how it develops has not been determined. Some research has suggested ...

The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. However, a group of researchers at the University of Pennsylvania, Philadelphia, has now identified a population of cells that are like pigment producing ...

The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. Researchers at the University of Pennsylvania, Philadelphia, have now identified a population of cells that are like pigment-producing cells in the skin in ...